We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-15.22%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$6.61B
AUM Growth
+$4.82B
Cap. Flow
+$4.36B
Cap. Flow %
65.91%
Top 10 Hldgs %
81.66%
Holding
104
New
21
Increased
10
Reduced
22
Closed
18

Top Buys

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.59B
2
YHOO
Yahoo Inc
YHOO
+$66.1M
3
EQC
Equity Commonwealth
EQC
+$24.8M
4
SNDK
SANDISK CORP
SNDK
+$20.5M
5
NYT icon
New York Times
NYT
+$18.5M

Top Sells

Rank Stock Value
1
ONIT
Onity Group
ONIT
+$30.2M
2
JD icon
JD.com
JD
+$26.2M
3
GDOT icon
Green Dot
GDOT
+$14.9M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$11.7M
5
CASC
Cascadian Therapeutics, Inc.
CASC
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 29.86%
2 Consumer Discretionary 2.36%
3 Energy 1.23%
4 Real Estate 0.93%
5 Financials 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NYT icon
26
New York Times
NYT
$11.6B
$18.3M 0.28%
+1,341,498
New +$18.5M
SNDK
27
DELISTED
SANDISK CORP
SNDK
$17.8M 0.27%
+305,808
New +$20.5M
CYTR
28
DELISTED
CytRx Corp
CYTR
$17.7M 0.27%
793,467
-85,731
-10% -$2.15M
BCRX icon
29
BioCryst Pharmaceuticals
BCRX
$2.37B
$17.5M 0.26%
1,171,897
-137,485
-10% -$1.56M
NRF
30
DELISTED
NorthStar Realty Finance Corp.
NRF
$16.7M 0.25%
525,000
+19,000
+4% +$683K
ANAC
31
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$15.3M 0.23%
198,246
-86,137
-30% -$5.65M
HALO icon
32
Halozyme
HALO
$9.72B
$15.2M 0.23%
672,883
-178,422
-21% -$3.14M
EPZM
33
DELISTED
Epizyme, Inc
EPZM
$14.7M 0.22%
610,442
-220,558
-27% -$4.24M
CSIQ icon
34
PUT
Canadian Solar
CSIQ
$906M
$14.3M 0.22%
500,000
– –
BRFS
35
DELISTED
BRF SA
BRFS
$14M 0.21%
668,626
– –
IBB icon
36
iShares Biotechnology ETF
IBB
$9.31B
$13.9M 0.21%
+112,908
New +$13.5M
CFG icon
37
Citizens Financial Group
CFG
$30.4B
$13.7M 0.21%
500,000
-120,000
-19% -$3.18M
IOVA icon
38
Iovance Biotherapeutics
IOVA
$2.23B
$13.1M 0.2%
1,433,700
+108,700
+8% +$1.21M
ZG icon
39
PUT
Zillow
ZG
$7.02B
$13M 0.2%
+450,000
New +$14M
MGM icon
40
MGM Resorts International
MGM
$11.7B
$12.5M 0.19%
685,600
– –
CALM icon
41
Cal-Maine
CALM
$4.28B
$12.1M 0.18%
+232,600
New +$11.4M
XNCR icon
42
Xencor
XNCR
$1.44B
$11.9M 0.18%
539,960
– –
ITB icon
43
iShares US Home Construction ETF
ITB
$2.41B
$11.5M 0.17%
418,200
-39,014
-9% -$1.06M
ARWR icon
44
Arrowhead Research
ARWR
$12.1B
$11.4M 0.17%
1,601,382
-500,128
-24% -$3.44M
ALXN
45
DELISTED
Alexion Pharmaceuticals
ALXN
$10.9M 0.16%
+60,039
New +$10.4M
NXEO
46
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$10.4M 0.16%
1,000,000
– –
TDW icon
47
PUT
Tidewater
TDW
$3.91B
$10.4M 0.16%
+14,164
New +$11.5M
ASMB icon
48
Assembly Biosciences
ASMB
$506M
$10.3M 0.16%
44,583
– –
FPRX
49
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$10.1M 0.15%
406,457
– –
ONIT
50
PUT
Onity Group
ONIT
$333M
$9.95M 0.15%
65,000
-56,920
-47% -$8.28M
1
2
3 4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q2 2015 Portfolio in Review

As of Q2 2015, QVT Financial held 104 positions worth $6.61B, up 268% from $1.8B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

QVT Financial deployed $4.36B of net new capital in Q2 2015, opening 21 new positions and adding to 10 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.53B.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was JD.com, an estimated $26.2M trimmed.

  • QVT Financial's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.53B.
  • QVT Financial added most to LL Flooring Holdings, Inc. in Q2 2015, an estimated $13.6M increase.
  • QVT Financial's biggest Q2 2015 reduction was JD.com, cutting an estimated $26.2M.
  • QVT Financial fully exited Onity Group in Q2 2015, selling an estimated $30.2M.
  • QVT Financial's ten largest holdings make up 82% of its $6.61B portfolio in Q2 2015.
  • QVT Financial opened 21 new positions and closed 18 in Q2 2015.
  • QVT Financial's portfolio value rose 268% quarter-over-quarter to $6.61B.

Based on QVT Financial's 13F filing for Q2 2015, filed 14 Aug 2015.